APD
55
-5
PRU
62
-2
O
20
-2
KHC
15
-2
UAL
77
-3
FLS
75
3
PM
58
-2
SE
65
2
LLY
57
4
BRK.B
38
-5
ALLE
35
-2
STX
45
-11
DNB
78
-4
STI
26
-5
DAL
70
-6
NKE
40
-2
TRV
55
-3
F
43
-3
DHI
50
-2
AAL
45
-2
APD
55
-5
PRU
62
-2
O
20
-2
KHC
15
-2
UAL
77
-3
FLS
75
3
PM
58
-2
SE
65
2
LLY
57
4
BRK.B
38
-5
ALLE
35
-2
STX
45
-11
DNB
78
-4
STI
26
-5
DAL
70
-6
NKE
40
-2
TRV
55
-3
F
43
-3
DHI
50
-2
AAL
45
-2
Financhill
Back

Beyond Vs. NovoCure Industry Stock Comparison

Sell
42

BYON
Beyond

Last Price:
6.31
Seasonality Move:
0.15%
Buy
77

NVCR
NovoCure

Last Price:
29.28
Seasonality Move:
2.04%
Sell
42
Beyond (BYON) is a Sell

Is Beyond a Buy, Sell or Hold?

  • The current Beyond [BYON] share price is $6.34. The Score for BYON is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • BYON is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BYON Stock Price Chart

What is Beyond's stock price today?

  • The Beyond share price today is $6.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BYON is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $30.51
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight selling pressure.

BYON Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 43.05 Sell
Chaikin Money Flow: 1528507 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.01 - 6.49) Buy
Bollinger Bands (100): (7.21 - 11.93) Sell

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.24 Buy
Relative Strength Index (14 RSI): 84.56 Buy
Chaikin Money Flow: -690353 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.69 - 22.01) Buy
Bollinger Bands (100): (15.44 - 20.28) Buy

BYON Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.1 Buy
20-day SMA: 6.18 Buy
50-day SMA: 7.96 Sell
200-day SMA: 16.17 Sell
8-day EMA: 6.2 Buy
20-day EMA: 6.43 Sell
50-day EMA: 7.68 Sell
200-day EMA: 13.55 Sell

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.45 Buy
20-day SMA: 18.85 Buy
50-day SMA: 17.12 Buy
200-day SMA: 17.34 Buy
8-day EMA: 23.1 Buy
20-day EMA: 19.92 Buy
50-day EMA: 18.23 Buy
200-day EMA: 19.07 Buy

Beyond Earnings Growth & BYON Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.45 per share, and an increase next year of $2.38 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.

Beyond Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):